Public Employees Retirement System of Ohio grew its stake in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 23.4% during the first quarter, Holdings Channel reports. The institutional investor owned 77,914 shares of the company’s stock after acquiring an additional 14,777 shares during the period. Public Employees Retirement System of Ohio’s holdings in HealthEquity were worth $6,511,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in HQY. Wasatch Advisors LP boosted its holdings in shares of HealthEquity by 9.3% in the first quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock valued at $601,949,000 after acquiring an additional 613,288 shares in the last quarter. Geode Capital Management LLC raised its holdings in HealthEquity by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 2,201,232 shares of the company’s stock worth $201,685,000 after purchasing an additional 5,671 shares in the last quarter. Westfield Capital Management Co. LP lifted its position in HealthEquity by 13.7% in the fourth quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock worth $178,864,000 after purchasing an additional 235,794 shares during the period. William Blair Investment Management LLC acquired a new stake in HealthEquity in the fourth quarter worth approximately $169,956,000. Finally, AQR Capital Management LLC lifted its position in HealthEquity by 59.3% in the third quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock worth $167,200,000 after purchasing an additional 656,820 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.
HealthEquity Price Performance
NASDAQ HQY opened at $101.24 on Wednesday. The stock has a market capitalization of $8.46 billion, a P/E ratio of 37.92, a P/E/G ratio of 1.67 and a beta of 0.21. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $105.96. The business’s fifty day moving average is $90.87 and its two-hundred day moving average is $84.93. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on HQY shares. Royal Bank Of Canada boosted their price objective on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Wells Fargo & Company set a $111.00 target price on HealthEquity in a research note on Monday, June 1st. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $85.00 to $105.00 in a research report on Thursday, April 9th. Finally, BTIG Research upped their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a report on Friday, July 24th. Eleven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $110.93.
Get Our Latest Stock Report on HQY
Insider Activity
In related news, EVP Michael Henry Fiore sold 2,354 shares of the stock in a transaction on Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the completion of the transaction, the executive vice president owned 52,244 shares in the company, valued at $4,963,180. This trade represents a 4.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This represents a 7.60% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock valued at $1,651,280 over the last three months. Insiders own 1.60% of the company’s stock.
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
